Company intelligence / Profile preview

Blue Owl Capital

New York City, New York, United Statesblueowl.com ↗

Ownership: Public · OWL
Employees: ~1200
Development stage: Commercial

Overview

Blue Owl Capital is a leading alternative asset management firm with over $273 billion in assets under management as of March 2025. It provides private capital solutions across credit, GP strategic capital, and real assets platforms. In the healthcare sector, following the acquisition of Cowen Healthcare Investments’ funds in late 2023, it manages dedicated life sciences strategies focused on mid-to-late-stage equity investments in biopharmaceuticals and medical technology companies[6][9]. Recent notable transactions include royalty financings for approved drugs such as Novartis' Pluvicto and BridgeBio Pharma’s acoramidis[7][10].

Industry: Investors

Partnerships

major financing deals with BridgeBio PharmaXOMA Corporation

Financials

Market cap: $16.3B
Total revenue: $753.1M
Enterprise value: $21B

Beyond the preview

Go deeper on Blue Owl Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blue Owl Capital.

Explore the full profile